ArticleTranslational lung cancer research2025
Deep structural lipidomic profiling reveals C=C positional isomers as potential biomarkers in lung adenocarcinoma tissue.
Article in Translational lung cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Recent evidence highlights the importance of lipid metabolic reprogramming in lung adenocarcinoma (LUAD) progression. Due to the limitations of conventional techniques, the fine structure of lipids cannot be identified. The metabolic changes of lipid structural features-particularly carbon-carbon double bond (C=C) positional isomers-remain underexplored. This study aims to characterize the structural alterations of lipids, especially C=C positional isomers, in LUAD tissues to elucidate their potential roles in tumor progression. Methods: We performed deep structural lipidomic profiling on paired normal lung (N) and LUAD (T) tissue samples using a combination of photochemical reaction-based structural analysis (Ω Analyzer) and liquid chromatography-mass spectrometry (LC-MS). Lipid species were characterized at three structural levels: lipid class, molecular species, and C=C positional isomer. Relative quantitative analyses were conducted to identify differences in total composition, unsaturation levels, and the distribution of C=C isomers between N and T groups. Results: A total of 794 phospholipid species were identified at the C=C isomer level, with the T group exhibiting a slightly higher overall number of identified lipids compared to the N group. Polyunsaturated lipids displayed notable upregulation in the T group and facilitated robust clustering between normal and cancer tissues. Furthermore, analyzing C=C positional isomers revealed significant differences in their relative abundances between the two groups: lipids enriched in C18:1(Δ9) were predominantly upregulated in T group samples, whereas those carrying C18:1(Δ8) were generally downregulated. Conclusions: Our findings demonstrate that deep structural lipidomic analysis yields crucial insights into the lipid reprogramming of LUAD. In particular, the relative abundances of C=C positional isomers hold promise as novel diagnostic markers and therapeutic targets for LUAD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.